The global vascular stents market size reached a value of almost USD 10.57 billion in the year 2023. The vascular stents industry is expected to grow at a compound annual growth rate (CAGR) of 5.5% between 2024 and 2032, reaching a value of almost USD 17.10 billion by 2032. This significant market expansion is driven by an increasing prevalence of cardiovascular diseases (CVD), advancements in medical technology, and an ageing global population. In this blog post, we’ll explore the key players, market segments, trends, COVID-19 impact, and future outlook in the vascular stents market.

What are Vascular Stents?

Vascular stents are small, tube-like devices that are inserted into blood vessels to keep them open and ensure proper blood flow. They are commonly used in the treatment of conditions such as atherosclerosis, coronary artery disease, and peripheral artery disease, where blood vessels become narrowed or blocked. Vascular stents are typically made from metal, polymer, or a combination of both, and may be coated with medication to reduce the risk of re-narrowing or restenosis. These devices are essential in treating various vascular disorders, improving blood circulation, and preventing severe complications such as stroke or heart attack.

Key Drivers of Growth

1. Prevalence of Cardiovascular Diseases (CVD): The increasing prevalence of cardiovascular diseases globally is one of the primary factors driving the growth of the vascular stents market. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, accounting for around 32% of all global deaths. This rising burden of CVDs is expected to continue driving demand for vascular stents, particularly coronary and peripheral stents.
2. Technological Advancements: Innovations in stent design and materials have significantly improved the outcomes of vascular stent procedures. Drug-eluting stents (DES) are a major breakthrough, as they release medication that helps prevent restenosis. Additionally, bioresorbable stents, which dissolve over time, are gaining traction as a promising alternative to traditional metal stents. These advancements are improving the overall effectiveness and safety of stent procedures, contributing to market growth.
3. Aging Population: The global population is ageing rapidly, with a significant increase in the number of elderly individuals. Ageing is a major risk factor for cardiovascular diseases, which makes the demand for vascular stents higher in geriatric populations. As a result, there is a growing need for vascular interventions, including stent placements, to manage cardiovascular conditions.
4. Government and Healthcare Investments: Governments and healthcare organizations around the world are increasing their investments in healthcare infrastructure and medical technologies. With the rising awareness of CVD and the benefits of timely stent procedures, healthcare providers are focusing more on offering these treatments. These investments are propelling the vascular stents market forward.

Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample

Key Market Segments

The vascular stents market can be segmented based on product type, application, and region. Here’s a breakdown of these key segments:

1. By Product Type:
   • Coronary Stents: These are the most widely used vascular stents and are specifically designed for coronary artery diseases. They are used to treat blockages or narrowing of the coronary arteries.
   • Peripheral Stents: These stents are used to treat peripheral artery diseases (PAD), which occur when blood vessels in the limbs become blocked or narrowed.
   • Carotid Stents: Used in the carotid arteries, these stents help reduce the risk of stroke by maintaining blood flow in the neck arteries.
   • Renal Stents: These are used to treat renal artery stenosis, a condition where the arteries supplying blood to the kidneys become narrow or blocked.
2. By Material:
   • Metal Stents: These are the traditional and most widely used type of stents. They are made from stainless steel, cobalt-chromium alloys, and other metals.
   • Drug-Eluting Stents (DES): These stents are coated with medication that helps prevent the re-narrowing of arteries by releasing drugs over time.
   • Bioresorbable Stents: These stents are designed to dissolve over time, reducing the need for long-term implantation. Bioresorbable stents are gaining popularity due to their potential advantages in reducing complications associated with permanent devices.
3. By End-User:
   • Hospitals: The largest market share in vascular stent procedures is held by hospitals, as they have the necessary infrastructure and expertise to perform stent implantation surgeries.
   • Ambulatory Surgical Centers (ASCs): With increasing outpatient procedures, ASCs are becoming a significant contributor to the market.

Key Market Players

The vascular stents market is highly competitive, with several leading companies at the forefront of innovation and market share. Some of the key players in the industry include:

• Medtronic PLC: A global leader in medical technologies, Medtronic is a key player in the vascular stents market with its range of coronary, peripheral, and bioresorbable stents.
• Abbott Laboratories: Abbott offers a wide portfolio of vascular stents, including drug-eluting stents (DES) and bioresorbable stents, serving both coronary and peripheral artery diseases.
• Boston Scientific Corporation: Known for its innovation in medical devices, Boston Scientific manufactures a broad range of stents, including DES and stents for peripheral artery disease.
• Johnson & Johnson (Cordis Corporation): As one of the leaders in the global medical device market, Cordis, a part of J&J, provides high-quality coronary stents and drug-eluting stents.
• Terumo Corporation: Terumo is a key player in the vascular stents market, particularly in the Asia-Pacific region, with a strong focus on coronary artery disease management.
• B. Braun Melsungen AG: B. Braun is a prominent company in the vascular stent industry, offering a range of products designed to address peripheral and coronary artery diseases.

Trends Shaping the Vascular Stents Market

1. Increase in Minimally Invasive Procedures: There is a growing trend towards minimally invasive procedures in cardiovascular care. Stent placement procedures, which can often be done through catheter-based interventions, reduce the need for open surgery, leading to quicker recovery times, reduced risks, and lower healthcare costs.
2. Personalized Treatment Approaches: With advancements in medical technologies, personalized treatments are becoming more common. For instance, stent selection based on a patient’s specific condition, genetics, and response to drugs is becoming more prevalent in clinical practice.
3. Integration of Digital Health Technologies: The integration of digital health tools, such as artificial intelligence (AI) and machine learning, into stent procedures is improving precision and patient outcomes. AI is increasingly being used to guide surgeons in selecting the right stent, ensuring optimal outcomes for patients.
4. Focus on Drug-Eluting Stents: Drug-eluting stents continue to be a significant area of growth in the vascular stents market, particularly in coronary artery disease treatment. These stents are coated with medication to reduce the risk of restenosis, making them a preferred option for many patients.
5. Advancements in Bioresorbable Stents: Bioresorbable stents are gaining attention due to their ability to dissolve after fulfilling their purpose, reducing long-term complications. The development of bioresorbable stents with enhanced durability and performance is expected to propel the market forward.

Impact of COVID-19 on the Vascular Stents Market

The COVID-19 pandemic has had a significant impact on the vascular stents market. During the peak of the pandemic, many elective surgeries, including stent placements, were postponed due to hospital prioritisation of COVID-19 patients and disruptions in healthcare services. This led to a temporary decline in the demand for vascular stents.

However, as the world recovers from the pandemic and healthcare systems stabilise, the market is expected to rebound. The importance of timely treatment for cardiovascular diseases has become more evident, and as a result, there is increasing demand for vascular interventions. Additionally, with the global focus on healthcare improvements and innovations, the post-pandemic period presents a significant opportunity for growth in the vascular stents market.

Market Size and Share

The global vascular stents market was valued at approximately USD 10.57 billion in 2023 and is projected to grow at a robust rate of 5.5% CAGR from 2024 to 2032. Factors contributing to this growth include the increasing incidence of cardiovascular diseases, advancements in stent technology, and the ageing global population. Geographically, North America currently holds the largest market share due to high healthcare expenditure, advanced healthcare infrastructure, and increasing awareness about cardiovascular diseases. The Asia-Pacific region is expected to experience significant growth, driven by expanding healthcare access and a growing elderly population.

Market Outlook

The vascular stents market is poised for sustained growth, with increasing demand for minimally invasive treatment options and advancements in medical technology. The emergence of bioresorbable and drug-eluting stents, combined with the rising prevalence of cardiovascular diseases, provides a solid foundation for market expansion. Moreover, as the global healthcare industry continues to recover from the COVID-19 pandemic, the vascular stents market is expected to experience a sharp rebound, further contributing to its growth trajectory.

With ongoing innovations, regulatory approvals, and increasing healthcare investments, the vascular stents market is set to evolve, offering new opportunities for both established players and new entrants to meet the growing global demand for cardiovascular interventions.

Related Trending Reports

https://www.expertmarketresearch.com/reports/human-insulin-market

https://www.expertmarketresearch.com/reports/proteasome-inhibitors-market

https://www.expertmarketresearch.com/clinical-trials/colorectal-cancer-drug-pipeline-analysis